Literature DB >> 18256546

The electrostatic surface of MDM2 modulates the specificity of its interaction with phosphorylated and unphosphorylated p53 peptides.

Christopher John Brown1, Deepa Srinivasan, Lee Hui Jun, David Coomber, Chandra S Verma, David P Lane.   

Abstract

Florescence anisotropy measurements using FAM-labelled p53 peptides showed that the binding of the peptides to MDM2 was dependant upon the phosphorylation of p53 at Thr18 and that this binding was modulated by the electrostatic properties of MDM2. In agreement with computational predictions, the binding to phosphorylated p53 peptide, in comparison to the unphosphorylated p53 peptide, was enhanced upon mutation of 3 key residues on the MDM2 surface.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18256546     DOI: 10.4161/cc.7.5.5488

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

Review 1.  Molecular simulations of protein dynamics: new windows on mechanisms in biology.

Authors:  Guy G Dodson; David P Lane; Chandra S Verma
Journal:  EMBO Rep       Date:  2008-02       Impact factor: 8.807

Review 2.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

3.  A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2.

Authors:  Karim M ElSawy; Adelene Sim; David P Lane; Chandra S Verma; Leo Sd Caves
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  p53 N-terminal phosphorylation: a defining layer of complex regulation.

Authors:  Lisa M Miller Jenkins; Stewart R Durell; Sharlyn J Mazur; Ettore Appella
Journal:  Carcinogenesis       Date:  2012-04-12       Impact factor: 4.944

5.  A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53.

Authors:  Jennifer A Fraser; Arumugam Madhumalar; Elizabeth Blackburn; Janice Bramham; Malcolm D Walkinshaw; Chandra Verma; Ted R Hupp
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

6.  A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function.

Authors:  Jennifer A Fraser; Borivoj Vojtesek; Ted R Hupp
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

Review 7.  The tumor suppressor p53: from structures to drug discovery.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-10       Impact factor: 10.005

8.  On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: a Brownian dynamics study.

Authors:  Karim M ElSawy; Chandra S Verma; Thomas L Joseph; David P Lane; Reidun Twarock; Leo S D Caves
Journal:  Cell Cycle       Date:  2013-01-16       Impact factor: 4.534

9.  Differences in the transactivation domains of p53 family members: a computational study.

Authors:  Jagadeesh N Mavinahalli; Arumugam Madhumalar; Roger W Beuerman; David P Lane; Chandra Verma
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

10.  Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.

Authors:  D P Teufel; M Bycroft; A R Fersht
Journal:  Oncogene       Date:  2009-04-13       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.